BEACON’s R&D is focused towards formulation development and adaptation for scale up production, improving existing products as well as drug delivery systems.

In-house R&D forms the backbone of our operations. Improving processes for existing API and formulation products. Formulation development and adaptation for scale up production with process validation; method validation is performed in collaboration with QA/QC. Stability study and shelf life determination of pharmaceutical products.

We have earned a name for maintaining world-class quality across all our manufacturing units, products and services.

We also leverage our R&D efforts to provide our customers with technical dossiers, plant layouts for pharmaceutical product manufacturing, development of processes and regulatory batches.

• Our formulation pipeline has several complex products for local as well as international markets majorly in Oncology, HIVs, CNS, CVS etc.
• BEACON’s R&D lab is equipped with state-of-the-art infrastructure for development of innovative technology products.
• We develop and apply skills to ensure the quality of its products right from the design to the manufacturing stage safeguarding patients’ safety and efficacy of the products.
• The development process for the products followed, ensures formulation development based on Quality by Design (QBD) principles enabling robust, reproducible and regulatory complied products in the market.